GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (OTCPK:AKUMQ) » Definitions » Forward Rate of Return (Yacktman) %

Akumin (Akumin) Forward Rate of Return (Yacktman) % : 0.00% (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Akumin Forward Rate of Return (Yacktman) %?

Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. Akumin's forward rate of return for was 0.00%.

The historical rank and industry rank for Akumin's Forward Rate of Return (Yacktman) % or its related term are showing as below:

AKUMQ's Forward Rate of Return (Yacktman) % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 16.575
* Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.

Unlike the Earnings Yield %, the Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Akumin Forward Rate of Return (Yacktman) % Historical Data

The historical data trend for Akumin's Forward Rate of Return (Yacktman) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akumin Forward Rate of Return (Yacktman) % Chart

Akumin Annual Data
Trend Sep15 Sep16 Sep17 Dec18 Dec19 Dec20 Dec21 Dec22
Forward Rate of Return (Yacktman) %
Get a 7-Day Free Trial - - - - -

Akumin Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Forward Rate of Return (Yacktman) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Akumin's Forward Rate of Return (Yacktman) %

For the Diagnostics & Research subindustry, Akumin's Forward Rate of Return (Yacktman) %, along with its competitors' market caps and Forward Rate of Return (Yacktman) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akumin's Forward Rate of Return (Yacktman) % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Akumin's Forward Rate of Return (Yacktman) % distribution charts can be found below:

* The bar in red indicates where Akumin's Forward Rate of Return (Yacktman) % falls into.



Akumin Forward Rate of Return (Yacktman) % Calculation

Forward Rate of Return is a concept that Don Yacktman uses in his investment approach. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. He said in the interview (March 2012, when the S&P 500 was at about 1400):

If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.

The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).

Akumin's Forward Rate of Return of Sep. 2023 is

Forward Rate of Return=Normalized Free Cash Flow/Price+5-Year EBITDA Growth Rate
=0/0.1459+0
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akumin  (OTCPK:AKUMQ) Forward Rate of Return (Yacktman) % Explanation

Unlike the Earnings Yield, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.

For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is to make it comparable to the growth rate.


Be Aware

In the Forward Rate of Return calculation, the growth rate is added directly to today's free cash flow yield. Therefore the calculation is reliable only if the company can grow at the same rate in the future as it did in the past. Investors should pay close attention to this when researching growth stocks. A more accurate measurement for return is Return on Capital.


Akumin Forward Rate of Return (Yacktman) % Related Terms

Thank you for viewing the detailed overview of Akumin's Forward Rate of Return (Yacktman) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Akumin (Akumin) Business Description

Traded in Other Exchanges
Address
8300 West Sunrise Boulevard, Plantation, FL, USA, 33322
Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.
Executives
Ronald J. Bienias officer: Chief Restructuring Officer C/O AKUMIN INC.,, 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Stonepeak Gp Investors Holdings Manager Llc 10 percent owner, other: See Remarks 55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Upper Holdings Lp 10 percent owner, other: See Remarks 55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Holdings Lp 10 percent owner, other: See Remarks 55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Krishna Kumar officer: See remarks C/O AKUMIN INC., 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Lawrence Ross Sinclair director 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
R. David Kretschmer officer: See Remarks 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Murray Lee director 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Scw Capital Management, Lp 10 percent owner 3131 TURTLE CREEK BLVD., SUITE 302, DALLAS TX 75219
Trinity Investment Group, Llc 10 percent owner 3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
Robert N. Cathey 10 percent owner 3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
John R. Wagner 10 percent owner 3838 OAK LAWN AVE., SUITE 450, DALLAS TX 75219
Paul Nelis officer: Chief Information Officer 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Haichen Huang director 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Matt Cameron officer: See Remarks 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322